Cargando…

Effect of Candesartan and Ramipril on Liver Fibrosis in Patients with Chronic Hepatitis C Viral Infection: A Randomized Controlled Prospective Study

Objective: This study aimed at evaluating the effects of candesartan and ramipril on liver fibrosis in patients with chronic hepatitis C. Methods: This randomized controlled prospective study involved 64 patients with chronic hepatitis C and liver fibrosis. Participants were randomized into 3 groups...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostafa, Tarek M., El-azab, Gamal A., Badra, Gamal A., Abdelwahed, Alyaa S., Elsayed, Abeer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649584/ https://www.ncbi.nlm.nih.gov/pubmed/34925649 http://dx.doi.org/10.1016/j.curtheres.2021.100654

Ejemplares similares

Protective Role of Ramipril and Candesartan against Myocardial Ischemic Reperfusion Injury: A Biochemical and Transmission Electron Microscopical Study
por: Sheik Uduman, Mohamed Saleem Thattakudian, et al.
Publicado: (2016)

The Effectiveness of 3 Combined Therapeutic Regimens in Egyptian Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: A Randomized Double-Blind Prospective Pilot Study
por: Mostafa, Tarek M., et al.
Publicado: (2021)

Ramipril: Aggravation of liver toxicity: case report
Publicado: (2020)

Role of Pentoxifylline and Sparfloxacin in Prophylaxis of Spontaneous Bacterial Peritonitis in Cirrhotic Patients
por: Mostafa, Tarek Mohammed, et al.
Publicado: (2014)

Ramipril + amlodipine and ramipril + hydrochlorothiazide fixed-dose combinations in relation to patient adherence
por: Simonyi, Gábor, et al.
Publicado: (2016)

Helicobacter pylori and Hepatitis C Virus Coinfection in Egyptian Patients
por: El-Masry, Samir, et al.
Publicado: (2010)

Regression of fibrosis in paediatric autoimmune hepatitis: morphometric assessment of fibrosis versus semiquantiatative methods
por: Abdalla, Ahmed F, et al.
Publicado: (2009)

Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis
por: Shi, Qin, et al.
Publicado: (2012)

Ramipril: Angioedema: case report
Publicado: (2021)

Serum Hyaluronic Acid: A Promising Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Shiha, Gamal
Publicado: (2008)

Lack of Any Relationship Between Circulating Autoantibodies and Interleukin–6 Levels in Egyptian Patients Infected with the Hepatitis C Virus
por: Nasr, Mohamed Y, et al.
Publicado: (2016)

Effect of Extracellular Matrix Stiffness on Candesartan Efficacy in Anti-Fibrosis and Antioxidation
por: Zhu, Tong, et al.
Publicado: (2023)

Candesartan in heart failure
por: Ripley, Toni L, et al.
Publicado: (2006)

Study of the inhibitory effects of chrysin and its nanoparticles on mitochondrial complex II subunit activities in normal mouse liver and human fibroblasts
por: Ragab, Eman M., et al.
Publicado: (2022)

Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril
por: Ekambaram, P, et al.
Publicado: (2011)

Ramipril-associated cholestasis in the setting of recurrent drug-induced liver injury
por: Forner, David, et al.
Publicado: (2017)

Accuracy of noninvasive methods for the diagnosis of liver fibrosis in children with chronic viral hepatitis
por: ElShahawy, A, et al.
Publicado: (2022)

Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis'
por: Wang, Di, et al.
Publicado: (2013)

Cost Effectiveness Analysis of Candesartan Therapy in Comparison to Candesartan-Amlodipine Therapy on Hypertensive Outpatients
por: Baroroh, Faridah, et al.
Publicado: (2019)

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis
por: Badra, Gamal, et al.
Publicado: (2006)

Ramipril poisoning rescued by naloxone and terlipressin
por: Samanta, Samanta, et al.
Publicado: (2014)

Ramipril in High-Risk Patients With COVID-19
por: Amat-Santos, Ignacio J., et al.
Publicado: (2020)

Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
por: Kilany, Shimaa, et al.
Publicado: (2021)

Treatment of diabetic vasculopathy with rosiglitazone and ramipril: Hype or hope?
por: Rahman, Sayeeda, et al.
Publicado: (2009)

New biomarkers of post-settlement growth in the sea urchin Strongylocentrotus purpuratus
por: Fadl, Alyaa Elsaid Abdelaziz, et al.
Publicado: (2017)

Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal
Publicado: (2011)

RP-HPLC Estimation of Ramipril and Telmisartan in Tablets
por: Kurade, V. P., et al.
Publicado: (2009)

Egy-Score Predicts Severe Hepatic Fibrosis and Cirrhosis in Egyptians With Chronic Liver Diseases: A Pilot Study
por: Alboraie, Mohamed A., et al.
Publicado: (2013)

Response to 'Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis' - authors' reply
por: Shi, Qin, et al.
Publicado: (2013)

Candesartan—the next anti-amyloid drug?
por: Yasar, Sevil
Publicado: (2022)

Allergic reaction related to ramipril use: a case report
por: Alencar, Renata C, et al.
Publicado: (2010)

Effect of ramipril on renal function in patients with intermittent claudication
por: Hobbs, Simon D, et al.
Publicado: (2008)

Accurate Prediction of Advanced Liver Fibrosis Using the Decision Tree Learning Algorithm in Chronic Hepatitis C Egyptian Patients
por: Hashem, Somaya, et al.
Publicado: (2016)

Effect of ramipril/hydrochlorothiazide and ramipril/canrenone combination on atrial fibrillation recurrence in hypertensive type 2 diabetic patients with and without cardiac autonomic neuropathy
por: Bosone, Daniele, et al.
Publicado: (2016)

Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
por: Omar, Mahmoud, et al.
Publicado: (2015)

Molecular Mechanism and Treatment of Viral Hepatitis-Related Liver Fibrosis
por: Su, Tung-Hung, et al.
Publicado: (2014)

Inhibition of angiotensin II type 1 receptor by candesartan reduces tumor growth and ameliorates fibrosis in colorectal cancer
por: Tabatabai, Ehsan, et al.
Publicado: (2021)

Candesartan cilexetil in the treatment of chronic heart failure
por: Baguet, Jean-Philippe, et al.
Publicado: (2009)

Cardio classics revisited – focus on the role of candesartan
por: De Rosa, Maria Leonarda
Publicado: (2010)

Preparation of Candesartan and Atorvastatin Nanoparticles by Solvent Evaporation (†)
por: Vaculikova, Eliska, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_kjgr62j7ielqemd3c1pn9pbnfb